1 minute read
Therapeutic digital viewer; watch TV to correct amblyopia
GADGETS
Recently the U.S. Food and Drug Administration (FDA) approved the market launch of Luminopia One This digital therapeutic device is transforming clinical practice because, through Artificial Intelligence (AI) algorithms, it can improve the eyesight of children between 4 and 7 years old who suffer from amblyopia, a condition listed as the leading cause of childhood vision loss, which occurs in approximately 3% of children and teenagers worldwide.
Advertisement
The success of the company Luminopia, which specializes in the development of digital therapies, focuses on the combination of medical treatment and fun, as children can choose from a collection of more than 700 hours of popular, attractive, and educational content while stimulating the teamwork of their eyes and their connection with the brain, all within a virtual reality (VR) headset.
This audiovisual material is modified in real-time through a patented and clinically proven algorithm. It is worth mentioning that this is the first FDA-approved digital therapy for children with amblyopia and, more broadly, the first for a neuro visual disorder. The official launch of Luminopia One is planned for the end of 2022.
Courtesy: https://thegadgetflow.com/blog/cool-ar-vr-gadgets-that-will-make-you-feel-like-youre-living-2050/
Source: https://luminopia.com/
